Business Wire

MED-EL Corporation Announces FDA Approval of Expanded Candidacy Indications and Hearing Preservation Results for the MED-EL Cochlear Implant System

DURHAM, N.C.--(BUSINESS WIRE)--Hearing implant leader MED-EL Corporation announced today the U.S. Food and Drug Administration (FDA) approval of new indications along with the first-ever approval of ...
Business Wire

FDA Approves MED-EL USA’s Cochlear Implants for Single-Sided Deafness and Asymmetric Hearing Loss

DURHAM, N.C.--(BUSINESS WIRE)--MED-EL USA announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s cochlear implant system for single-sided deafness (SSD) and ...